After Onglyza and Kombiglyze XR were released onto the market in 2009 and 2010 (respectively), researchers hailed the new drugs as the next major innovation in diabetes treatment after the invention of insulin a century prior. However it needs to be stressed that DPP-4 inhibitors may be linked to some pretty nasty side-effects. How the Drugs … [Read more...]